Laparoscopic/robotic simple prostatectomy

Rao S. Mandalapu; Adnan Ali; Sailaja Pisipati; Ashutosh K. Tewari

doi:10.1007/978-1-4939-1587-3_15

Laparoscopic/robotic simple prostatectomy

Rao S. Mandalapu, Adnan Ali, Sailaja Pisipati, Ashutosh K. Tewari

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Benign prostatic hyperplasia is the most common benign neoplasm in American men, affecting nearly 6.5 million men aged 50-79 years in the United States. The treatment options for clinically significant benign prostatic hyperplasia have dramatically changed in the recent past with the development of minimally invasive procedures and advanced medical therapies. However, open prostatectomy remains the surgery of choice in selected patients. Simple prostatectomy used to be the primary treatment of choice for symptomatic patients with benign prostatic hyperplasia (BPH). In an attempt to reduce the length of hospital stay and morbidity associated with open prostatectomy, minimally invasive approaches have evolved. Robot-assisted simple prostatectomy (RASP) holds potential for improving perioperative outcomes following simple prostatectomy. In this chapter we briefly describe the indications, contraindications, prevalent techniques, and complications of RASP.

Original language	English
Title of host publication	Treatment of Benign Prostatic Hyperplasia
Subtitle of host publication	Modern Alternative to Transurethral Resection of the Prostate
Publisher	Springer New York
Pages	113-120
Number of pages	8
ISBN (Electronic)	9781493915873
ISBN (Print)	9781493915866
DOIs	https://doi.org/10.1007/978-1-4939-1587-3_15
State	Published - 1 Jan 2015

Access to Document

10.1007/978-1-4939-1587-3_15

Cite this

@inbook{68dccc9c287f47a4ad41a82dc3adb8dc,

title = "Laparoscopic/robotic simple prostatectomy",

abstract = "Benign prostatic hyperplasia is the most common benign neoplasm in American men, affecting nearly 6.5 million men aged 50-79 years in the United States. The treatment options for clinically significant benign prostatic hyperplasia have dramatically changed in the recent past with the development of minimally invasive procedures and advanced medical therapies. However, open prostatectomy remains the surgery of choice in selected patients. Simple prostatectomy used to be the primary treatment of choice for symptomatic patients with benign prostatic hyperplasia (BPH). In an attempt to reduce the length of hospital stay and morbidity associated with open prostatectomy, minimally invasive approaches have evolved. Robot-assisted simple prostatectomy (RASP) holds potential for improving perioperative outcomes following simple prostatectomy. In this chapter we briefly describe the indications, contraindications, prevalent techniques, and complications of RASP.",

author = "Mandalapu, {Rao S.} and Adnan Ali and Sailaja Pisipati and Tewari, {Ashutosh K.}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-1587-3_15",

language = "English",

isbn = "9781493915866",

pages = "113--120",

booktitle = "Treatment of Benign Prostatic Hyperplasia",

publisher = "Springer New York",

address = "United States",

}

TY - CHAP

T1 - Laparoscopic/robotic simple prostatectomy

AU - Mandalapu, Rao S.

AU - Ali, Adnan

AU - Pisipati, Sailaja

AU - Tewari, Ashutosh K.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Benign prostatic hyperplasia is the most common benign neoplasm in American men, affecting nearly 6.5 million men aged 50-79 years in the United States. The treatment options for clinically significant benign prostatic hyperplasia have dramatically changed in the recent past with the development of minimally invasive procedures and advanced medical therapies. However, open prostatectomy remains the surgery of choice in selected patients. Simple prostatectomy used to be the primary treatment of choice for symptomatic patients with benign prostatic hyperplasia (BPH). In an attempt to reduce the length of hospital stay and morbidity associated with open prostatectomy, minimally invasive approaches have evolved. Robot-assisted simple prostatectomy (RASP) holds potential for improving perioperative outcomes following simple prostatectomy. In this chapter we briefly describe the indications, contraindications, prevalent techniques, and complications of RASP.

AB - Benign prostatic hyperplasia is the most common benign neoplasm in American men, affecting nearly 6.5 million men aged 50-79 years in the United States. The treatment options for clinically significant benign prostatic hyperplasia have dramatically changed in the recent past with the development of minimally invasive procedures and advanced medical therapies. However, open prostatectomy remains the surgery of choice in selected patients. Simple prostatectomy used to be the primary treatment of choice for symptomatic patients with benign prostatic hyperplasia (BPH). In an attempt to reduce the length of hospital stay and morbidity associated with open prostatectomy, minimally invasive approaches have evolved. Robot-assisted simple prostatectomy (RASP) holds potential for improving perioperative outcomes following simple prostatectomy. In this chapter we briefly describe the indications, contraindications, prevalent techniques, and complications of RASP.

UR - http://www.scopus.com/inward/record.url?scp=84944058159&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1587-3_15

DO - 10.1007/978-1-4939-1587-3_15

M3 - Chapter

AN - SCOPUS:84944058159

SN - 9781493915866

SP - 113

EP - 120

BT - Treatment of Benign Prostatic Hyperplasia

PB - Springer New York

ER -

Laparoscopic/robotic simple prostatectomy

Abstract

Access to Document

Fingerprint

Cite this